Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Efficacy of an AI Delivered, Neurosymbolic, Human Supervised Digital Intervention for Depression and Anxiety Versus Standard Cognitive Behavioural Therapy in Young Persons and Adults

NCT07620340 is registered in ClinicalTrials.gov with PsyScale as lead sponsor.

NCT NCT07620340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07620340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Efficacy of an AI Delivered, Neurosymbolic, Human Supervised Digital Intervention for Depression and Anxiety Versus Standard Cognitive Behavioural Therapy in Young Persons and Adults
Lead sponsor
PsyScale
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
January 7, 2027
Enrollment
400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

generalized anxiety disorder (gad), major depressive disorder (mdd)